Eclazolast

• CAT Number: I026697
• CAS Number: 80263-73-6
• Molecular Formula: C12H12ClNO4
• Molecular Weight: 269.68
• Purity: 98%
• Synonyms: Eclazolast; RHC 2871; RHC-2871; RHC2871; REV 2871; REV2871; REV-2871.
• Solubility: Soluble in DMSO
• Appearance: Solid powder
• Storage: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
• IUPAC Name: 2-ethoxyethyl 5-chloro-1,3-benzoxazole-2-carboxylate
• InChI: InChI=1S/C12H12ClNO4/c1-2-16-5-6-17-12(15)11-14-9-7-8(13)3-4-10(9)18-11/h3-4,7H,2,5-6H2,1H3
• InChIKey: HNJUBRBHULQQFX-UHFFFAOYSA-N
• SMILES: CCOCCOC(=O)C1=NC2=C(O1)C=CC(=C2)Cl

Eclazolast（Cat No.:I026697）is an investigational drug that acts as a selective antagonist of the leukotriene receptor, specifically targeting the CysLT1 receptor. It is being studied for its potential to treat conditions like asthma, allergic rhinitis, and other inflammatory disorders where leukotrienes play a key role in promoting inflammation and bronchoconstriction. By blocking this receptor, eclazolast may help reduce airway inflammation and improve lung function. Currently, it is in the clinical trial phase, and its safety, efficacy, and therapeutic potential are still being evaluated for various respiratory conditions.